Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-17

Clinical Trial Update: Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks [Phase 2]

View source ↗

Summary

Phase 2 trial investigating optimal timing (6 vs 12 weeks) for surgery after pre-operative radiotherapy in rectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Adenocarcinoma of the Rectum, Adenocarcinoma | Phase 2 | Status: UNKNOWN